POMPE - DISEASE
Drug
GENZYME CORPORATION
Total Payments
$421,071
Transactions
2,392
Doctors
1,323
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $108,144 | 1,029 | 770 |
| 2018 | $115,232 | 691 | 467 |
| 2017 | $197,695 | 672 | 411 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $376,244 | 237 | 89.4% |
| Food and Beverage | $39,049 | 2,153 | 9.3% |
| Grant | $3,000 | 1 | 0.7% |
| Charitable Contribution | $2,777 | 1 | 0.7% |
Payments by Type
Research
$376,244
237 transactions
General
$44,826
2,155 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Pompe Registry | GENZYME CORPORATION | $85,616 | 0 |
| Pompe Disease Registry | GENZYME CORPORATION | $61,781 | 0 |
| Q4 2016 Pompe LSD Registry | GENZYME CORPORATION | $52,725 | 0 |
| Q2 2017 Pompe LSD Registry | GENZYME CORPORATION | $44,377 | 0 |
| Q1 2017 Pompe LSD Registry | GENZYME CORPORATION | $30,733 | 0 |
| Q3 2017 Pompe LSD Registry | GENZYME CORPORATION | $29,356 | 0 |
| Pompe LSD Data Registry | GENZYME CORPORATION | $29,015 | 0 |
| Pompe Disease Registry Protocol and Pregnancy Subregistry Protocol | GENZYME CORPORATION | $19,234 | 0 |
| Pompe Registry Program | GENZYME CORPORATION | $5,595 | 0 |
| Pompe Disease Registry Protocol and Pregnancy Sub-Registry Protocol | SANOFI US SERVICES INC. | $4,760 | 0 |
| Q3 2017 Pompe LSD Registry | GENZYME CORPORATION | $3,213 | 0 |
| Q3 2016 Pompe LSD Registry | GENZYME CORPORATION | $2,200 | 0 |
| IRB Annual Review | GENZYME CORPORATION | $2,040 | 0 |
| Pompe Registry Program, Continuing Review-Investigator WIRB Study # 1060150 | GENZYME CORPORATION | $1,470 | 0 |
| Rare Disease Registry Program | GENZYME CORPORATION | $875.00 | 0 |
| IRB Annual Review for Gaucher, Pompe, Fabry and MPSI Registry | GENZYME CORPORATION | $680.00 | 0 |
| Gaucher Disease Registry Protocol and Pregnancy Sub-Registry Protocol | GENZYME CORPORATION | $630.00 | 0 |
| Pompe Disease Registry IRB fee for initial review & site start up fees | GENZYME CORPORATION | $625.00 | 0 |
| LSD-Registry Protocol | GENZYME CORPORATION | $475.00 | 0 |
| Q1 2018 Pompe LSD Registry | GENZYME CORPORATION | $250.00 | 0 |
Top Doctors Receiving Payments for POMPE - DISEASE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Ann Arbor, MI | $379,021 | 238 |
| , M.D | Neurology | Phoenix, AZ | $3,000 | 1 |
| , MD | Neurology | Baton Rouge, LA | $249.13 | 12 |
| , MD | Neuromuscular Medicine | Cincinnati, OH | $234.89 | 27 |
| , MD | Neurology | Baton Rouge, LA | $201.89 | 10 |
| , M.D | Neurology | Aurora, CO | $193.72 | 9 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Valdosta, GA | $172.55 | 11 |
| , M.D | Neurology | Tyler, TX | $166.16 | 9 |
| , MD | Neurology | Valdosta, GA | $154.49 | 10 |
| , M.D | Internal Medicine | Detroit, MI | $153.74 | 3 |
| , M.D | Internal Medicine | Greenwood, SC | $151.19 | 9 |
| , MD | Neurology | Cincinnati, OH | $131.23 | 6 |
| , M.D., FACS, FACRS | Colon & Rectal Surgery | Vestal, NY | $127.47 | 8 |
| , M.D | Neurology | Newnan, GA | $126.88 | 9 |
| , M.D | Neurology | Newnan, GA | $126.88 | 9 |
| , MD | Neurology | Greenville, SC | $126.79 | 7 |
| , DO | Student in an Organized Health Care Education/Training Program | Cincinnati, OH | $122.52 | 6 |
| , M.D | Neurology | Sterling, IL | $121.84 | 6 |
| , M.D | Rheumatology | South Windsor, CT | $119.08 | 7 |
| , M.D | Internal Medicine | Los Angeles, CA | $118.67 | 2 |
| , M.D | Neurology | Fairfield, CT | $118.40 | 6 |
| Rachel Donaldson | Neurology | Cleveland, OH | $116.40 | 6 |
| , MD | Neurology | Danville, IN | $115.24 | 5 |
| , M.D | Neurology | Tampa, FL | $114.05 | 6 |
| , MD | Neurology with Special Qualifications in Child Neurology | Indianapolis, IN | $113.67 | 6 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $416,242
- SANOFI US SERVICES INC. $4,760
- SANOFI-AVENTIS U.S. LLC $68.70
Product Information
- Type Drug
- Total Payments $421,071
- Total Doctors 1,323
- Transactions 2,392
About POMPE - DISEASE
POMPE - DISEASE is a drug associated with $421,071 in payments to 1,323 healthcare providers, recorded across 2,392 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2019. In 2019, $108,144 was paid across 1,029 transactions to 770 doctors.
The most common payment nature for POMPE - DISEASE is "Unspecified" ($376,244, 89.4% of total).
POMPE - DISEASE is associated with 20 research studies, including "Pompe Registry" ($85,616).